[ad_1]
By the hand of Nidhi Verma
NEW DELHI (Reuters) – Indian Prime Minister Narendra Modi has told officials to review plans to ease travel restrictions as concerns over the new Omicron rise https://www.reuters.com/business/healthcare-pharmaceuticals/japan-tighten-border -controls- s-africa-others-new-virus-variant-jiji-2021-11-26 COVID-19 variant.
The second country in the world affected by the pandemic only decided to start again on Friday https://www.reuters.com/world/india/india-tighten-covid-19-testing-tourists-amid-new-variant-concerns- 2021-11-26 international flights from countries considered “at risk” for coronaviruses, while a rigorous border study has been ordered.
But after the World Health Organization (WHO) said the new variant was “worrying”, Modik stressed “the need to monitor all international arrivals, paying special attention to countries identified as” at risk “in their testing guidelines. The government said in a statement that it had met with officials to review the status of COVID-19 and vaccines.
The WHO said Omicron, initially detected in South Africa, could spread faster than other forms.
This week, India has seen the lowest increase in new cases in a year and a half, as vaccines and antibodies have increased in a large part of its population as a result of previous infections.
The nation’s daily cases have been halved since September. It has reported 8,318 new cases in the last 24 hours.
But the new variant, with a protein spike that is very different from the vaccine-based coronavirus, has sparked global alarms and scared the financial markets.
Modik said people need to be more cautious and take appropriate measures such as wearing masks and social distance.
“He spoke of the need to be proactive in the new variant,” the statement said.
“He promised that intensive care and active surveillance should be followed in clusters reporting the highest cases and that technical assistance should be provided to states that are currently reporting higher cases.”
Modik told officials to expedite coverage of the second dose.
Fusion Media or anyone involved with Fusion Media will not be liable for any loss or damage as a result of relying on the information contained in the data, estimates, charts and buy / sell signals contained on this website. Please be fully informed about the risks and costs associated with trading in the financial markets, which is one of the most risky forms of investment possible.
[ad_2]
Source link
